Remboursement urgent du médicament Stelara (QO 006875C).

This procedure is a parliamentary question concerning the urgent reimbursement of Stelara, a medication used to treat certain autoimmune diseases. It seeks to address delays or issues in ensuring patients have affordable access to this specific treatment. This affects patients requiring Stelara and the healthcare providers and insurance systems responsible for medication reimbursement in Belgium.